242 related articles for article (PubMed ID: 28289277)
1. CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
Orhan F; Fatouros-Bergman H; Goiny M; Malmqvist A; Piehl F; ; Cervenka S; Collste K; Victorsson P; Sellgren CM; Flyckt L; Erhardt S; Engberg G
Mol Psychiatry; 2018 May; 23(5):1244-1250. PubMed ID: 28289277
[TBL] [Abstract][Full Text] [Related]
2. GABA levels in CSF of patients with psychiatric disorders.
Gold BI; Bowers MB; Roth RH; Sweeney DW
Am J Psychiatry; 1980 Mar; 137(3):362-4. PubMed ID: 7356067
[TBL] [Abstract][Full Text] [Related]
3. CSF levels of gamma-aminobutyric acid in schizophrenia. Low values in recently ill patients.
van Kammen DP; Sternberg DE; Hare TA; Waters RN; Bunney WE
Arch Gen Psychiatry; 1982 Jan; 39(1):91-7. PubMed ID: 7055411
[TBL] [Abstract][Full Text] [Related]
4. Anxiety in major depression and cerebrospinal fluid free gamma-aminobutyric acid.
Mann JJ; Oquendo MA; Watson KT; Boldrini M; Malone KM; Ellis SP; Sullivan G; Cooper TB; Xie S; Currier D
Depress Anxiety; 2014 Oct; 31(10):814-21. PubMed ID: 24865448
[TBL] [Abstract][Full Text] [Related]
5. Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients.
de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Jung-Cook H; Solís-Vivanco R; Graff-Guerrero A; Shungu DC
Biol Psychiatry; 2018 Mar; 83(6):475-483. PubMed ID: 29132653
[TBL] [Abstract][Full Text] [Related]
6. Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis.
Orhan F; Schwieler L; Fatouros-Bergman H; Malmqvist A; Cervenka S; Collste K; Flyckt L; Farde L; Sellgren CM; Piehl F; ; Engberg G; Erhardt S
Acta Psychiatr Scand; 2018 Nov; 138(5):432-440. PubMed ID: 30132802
[TBL] [Abstract][Full Text] [Related]
7. Deficient inhibitory cortical networks in antipsychotic-naive subjects at risk of developing first-episode psychosis and first-episode schizophrenia patients: a cross-sectional study.
Hasan A; Wobrock T; Grefkes C; Labusga M; Levold K; Schneider-Axmann T; Falkai P; Müller H; Klosterkötter J; Bechdolf A
Biol Psychiatry; 2012 Nov; 72(9):744-51. PubMed ID: 22502988
[TBL] [Abstract][Full Text] [Related]
8. CSF dopamine is elevated in first-episode psychosis and associates to symptom severity and cognitive performance.
Orhan F; Goiny M; Becklén M; Mathé L; Piehl F; Schwieler L; Fatouros-Bergman H; Farde L; Cervenka S; Sellgren CM; Engberg G; Erhardt S
Schizophr Res; 2023 Jul; 257():34-40. PubMed ID: 37271040
[TBL] [Abstract][Full Text] [Related]
9. Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders - An individual patient data meta-analysis.
Campana M; Yakimov V; Moussiopoulou J; Maurus I; Löhrs L; Raabe F; Jäger I; Mortazavi M; Benros ME; Jeppesen R; Meyer Zu Hörste G; Heming M; Giné-Servén E; Labad J; Boix E; Lennox B; Yeeles K; Steiner J; Meyer-Lotz G; Dobrowolny H; Malchow B; Hansen N; Falkai P; Siafis S; Leucht S; Halstead S; Warren N; Siskind D; Strube W; Hasan A; Wagner E
Brain Behav Immun; 2024 Jul; 119():353-362. PubMed ID: 38608742
[TBL] [Abstract][Full Text] [Related]
10. Schizophrenia, tardive dyskinesia, and brain GABA.
Perry TL; Hansen S; Jones K
Biol Psychiatry; 1989 Jan; 25(2):200-6. PubMed ID: 2564786
[TBL] [Abstract][Full Text] [Related]
11. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
[TBL] [Abstract][Full Text] [Related]
12. CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder.
Sharma RP; Janicak PG; Bissette G; Nemeroff CB
Am J Psychiatry; 1997 Jul; 154(7):1019-21. PubMed ID: 9210757
[TBL] [Abstract][Full Text] [Related]
13. gamma-Aminobutyric acid concentration in cerebrospinal fluid in schizophrenia.
McCarthy BW; Gomes UR; Neethling AC; Shanley BC; Taljaard JJ; Potgieter L; Roux JT
J Neurochem; 1981 Apr; 36(4):1406-8. PubMed ID: 7264636
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the density of gamma-aminobutyric acid in the ventromedial prefrontal cortex of patients with first-episode psychosis and healthy controls.
Yang Z; Zhu Y; Song Z; Mei L; Zhang J; Chen T; Wang Y; Xu Y; Jiang K; Li Y; Liu D
Shanghai Arch Psychiatry; 2015 Dec; 27(6):341-7. PubMed ID: 27199525
[TBL] [Abstract][Full Text] [Related]
15. Neurogranin as a potential synaptic marker in the cerebrospinal fluid of patients with a first episode psychosis.
Santillo AF; Lundgren S; Xu C; Orhan F; Fatouros-Bergman H; Blennow K; Zetterberg H; Portelius E; ; Cervenka S; Jönsson EG; Erhardt S; Engberg G
Schizophr Res; 2019 Jun; 208():490-492. PubMed ID: 30733168
[No Abstract] [Full Text] [Related]
16. The relationship between cortical inhibition, antipsychotic treatment, and the symptoms of schizophrenia.
Liu SK; Fitzgerald PB; Daigle M; Chen R; Daskalakis ZJ
Biol Psychiatry; 2009 Mar; 65(6):503-9. PubMed ID: 18950746
[TBL] [Abstract][Full Text] [Related]
17. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology.
Pillai A; Kale A; Joshi S; Naphade N; Raju MS; Nasrallah H; Mahadik SP
Int J Neuropsychopharmacol; 2010 May; 13(4):535-9. PubMed ID: 19941699
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid proteomic signatures are associated with symptom severity of first-episode psychosis.
Haroon H; Ho AM; Gupta VK; Dasari S; Sellgren CM; Cervenka S; Engberg G; Eren F; Erhardt S; Sung J; Choi DS
J Psychiatr Res; 2024 Mar; 171():306-315. PubMed ID: 38340697
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
[TBL] [Abstract][Full Text] [Related]
20. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
